Cyramza 10 mg/ml concentrate for solution for infusion clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
PRODIGE 55-SOCRATE : A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer
This study is looking at new ways to treat advanced stomach cancer in older patients. It compares two treatments, ramucirumab alone or with paclitaxel, to see which helps people live longer and have a better quality of life.
For: stomach cancer stage IV with metastasesFrance - Ongoing, recruitingTherapeutic exploratory (Phase II)
A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well differentiated metastatic pancreatic neuroendocrine tumors
This study looks at a new treatment called Cyramza combined with a common chemotherapy, dacarbazine, for a specific type of pancreatic cancer that has spread. We want to see if this combination can help control the cancer's growth for at least six months.
For: Progressive well-differentiated metastatic neuroendocrine tumors of the pancreasGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy - The Phase II/III RAMIRIS STUDY
This study is looking at new ways to treat stomach or food pipe cancer that has spread or come back, after initial chemotherapy hasn't worked. It compares two different combinations of medicines to see which is more effective at helping people live longer and shrinking their cancer.
For: advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions · who failed prior line of palliative chemotherpayItaly · Austria · Germany